Αποτελέσματα Αναζήτησης
21 Δεκ 2022 · Brilinta (generic name: ticagrelor) is an oral antiplatelet prescription tablet for adults that is usually taken twice a day, in the morning and the evening. It is classified as a P2Y 12 inhibitor and works by making your platelets less sticky to help prevent blood clots from forming.
12 Ιουν 2024 · Yes, a generic for Brilinta has been approved by the FDA. The generic medicine name for Brilinta is ticagrelor. Generic ticagrelor 90mg from the manufacturer Hisun Pharm Hangzhou has been approved by the FDA on January 23, 2019 but is not available in pharmacies yet.
20 Ιουλ 2011 · A generic version of Brilinta has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Brilinta and have been approved by the FDA: ticagrelor tablet;oral. Manufacturer: ALKEM LABS LTD.
17 Μαΐ 2024 · Common Brand Name(s): Brilinta; Common Generic Name(s): ticagrelor; Pronunciation: brih-LIN-tah; Drug Classes: antiplatelet; P2Y12 platelet inhibitor; Availability: prescription only; no...
8 Ιαν 2022 · Is Brilinta a blood thinner or anticoagulant? Yes, Brilinta is considered a blood thinner. It’s an antiplatelet drug that works by stopping your platelets from being activated. Platelets are ...
4 Οκτ 2021 · Brilinta is a P2Y12 platelet inhibitor used in adults with acute coronary syndrome (blocked blood flow to heart) or a history of heart attack and more.
Ticagrelor, sold under the brand name Brilinta among others, is a medication used for the prevention of stroke, heart attack and other events in people with acute coronary syndrome, meaning problems with blood supply in the coronary arteries. It acts as a platelet aggregation inhibitor by antagonising the P2Y 12 receptor. [7] .
